Literature DB >> 26510739

Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism.

Peter Ranger1, Bart A Ellenbroek2.   

Abstract

Valproic acid or valproate (VPA) is an anti-convulsant and mood stabiliser effective in treating epilepsy and bipolar disorders. Although in adults VPA is well tolerated and safe, there is convincing evidence that it has teratogenic properties, ranging from mild neurodevelopmental changes to severe congenital malformations. In particular, studies involving humans and other animals have shown that prenatal exposure to VPA can induce developmental abnormalities reminiscent of autism spectrum disorder (ASD). In this chapter, we discuss the connection between VPA and ASD, evaluate the VPA animal model of ASD, and describe the possible molecular mechanisms underlying VPA's teratogenic properties.

Entities:  

Keywords:  ASD; Animal models; Autism; Behaviour; HDAC-I; Oxidative stress; ROS; Teratogen; VPA; Valproate; Valproic Acid

Mesh:

Substances:

Year:  2016        PMID: 26510739     DOI: 10.1007/7854_2015_404

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  12 in total

Review 1.  Turing Revisited: Decoding the microRNA Messages in Brain Extracellular Vesicles for Early Detection of Neurodevelopmental Disorders.

Authors:  Virginie Gillet; Darel John Hunting; Larissa Takser
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Comprehensive Analysis of Metabolic Changes in Male Mice Exposed to Sodium Valproate Based on GC-MS Analysis.

Authors:  Yahao Gao; Di Jiang; Changshui Wang; Gang An; Li Zhu; Changmeng Cui
Journal:  Drug Des Devel Ther       Date:  2022-06-17       Impact factor: 4.319

3.  Modulation of sphingosine 1-phosphate (S1P) attenuates spatial learning and memory impairments in the valproic acid rat model of autism.

Authors:  Hongmei Wu; Quanzhi Zhang; Jingquan Gao; Caihong Sun; Jia Wang; Wei Xia; Yonggang Cao; Yanqiu Hao; Lijie Wu
Journal:  Psychopharmacology (Berl)       Date:  2017-12-07       Impact factor: 4.530

4.  Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition.

Authors:  Bart A Ellenbroek; Caren August; Jiun Youn
Journal:  Front Neurosci       Date:  2016-09-21       Impact factor: 4.677

Review 5.  Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?

Authors:  Alastair Macfarlane; Trisha Greenhalgh
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-01       Impact factor: 3.007

6.  Reward-Related Behavioral, Neurochemical and Electrophysiological Changes in a Rat Model of Autism Based on Prenatal Exposure to Valproic Acid.

Authors:  Sara Schiavi; Daniela Iezzi; Antonia Manduca; Stefano Leone; Francesca Melancia; Carmen Carbone; Michele Petrella; Guido Mannaioni; Alessio Masi; Viviana Trezza
Journal:  Front Cell Neurosci       Date:  2019-10-25       Impact factor: 5.505

7.  Timing and Intertemporal Choice Behavior in the Valproic Acid Rat Model of Autism Spectrum Disorder.

Authors:  William E DeCoteau; Adam E Fox
Journal:  J Autism Dev Disord       Date:  2021-06-11

8.  Neuroglia in the autistic brain: evidence from a preclinical model.

Authors:  Maria Rosanna Bronzuoli; Roberta Facchinetti; Davide Ingrassia; Michela Sarvadio; Sara Schiavi; Luca Steardo; Alexei Verkhratsky; Viviana Trezza; Caterina Scuderi
Journal:  Mol Autism       Date:  2018-12-27       Impact factor: 7.509

Review 9.  Toward a Better Understanding of Neuronal Migration Deficits in Autism Spectrum Disorders.

Authors:  Yi-Hsuan Pan; Nan Wu; Xiao-Bing Yuan
Journal:  Front Cell Dev Biol       Date:  2019-09-20

10.  Micromolar Valproic Acid Doses Preserve Survival and Induce Molecular Alterations in Neurodevelopmental Genes in Two Strains of Zebrafish Larvae.

Authors:  Andrea Messina; Alessandra Boiti; Valeria Anna Sovrano; Paola Sgadò
Journal:  Biomolecules       Date:  2020-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.